Hunan Nucien Pharmaceutical Co., Ltd. (SHA:688189)

China flag China · Delayed Price · Currency is CNY
7.99
-0.16 (-1.96%)
Mar 9, 2026, 4:00 PM EDT
19.97%
Market Cap 2.24B
Revenue (ttm) 141.93M
Net Income (ttm) -137.25M
Shares Out 272.56M
EPS (ttm) -0.50
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 3,865,660
Average Volume 4,754,342
Open 8.07
Previous Close 8.15
Day's Range 7.97 - 8.12
52-Week Range 5.42 - 18.78
Beta 0.16
RSI 40.30
Earnings Date Apr 24, 2026

About SHA:688189

Hunan Nucien Pharmaceutical Co., Ltd., a pharmaceutical company, engages in the research and development, production, and sale of chemical drugs in China. The company also focuses on the research, development, production, and sales of antiviral drugs, including influenza and infectious disease prevention and treatment drugs, as well as medicines for anti-influenza, malignant tumors, cardiovascular, antibiotics, antipyretics, pain relief, diabetes, analgesic, cerebrovascular, respiratory, and other pharmaceutical fields. Hunan Nucien Pharmaceuti... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 319
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688189
Full Company Profile

Financial Performance

In 2025, SHA:688189's revenue was 141.93 million, a decrease of -46.09% compared to the previous year's 263.28 million. Losses were -137.25 million, -61.54% less than in 2024.

Financial Statements

News

There is no news available yet.